iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$10.60 USD
+0.03 (0.28%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $10.61 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-1.02 | 0.00% |
Earnings Summary
For their last quarter, iTeos Therapeutics (ITOS) reported earnings of -$0.85 per share, beating the Zacks Consensus Estimate of $-1.03 per share. This reflects a positive earnings surprise of 17.48%. Look out for ITOS's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$1.02 per share, reflecting a year-over-year decrease of 131.82%.
Earnings History
Price & Consensus
Zacks News for ITOS
Wall Street Analysts Believe iTeos Therapeutics, Inc. (ITOS) Could Rally 243.43%: Here's is How to Trade
ITOS: What are Zacks experts saying now?
Zacks Private Portfolio Services